Molecular Classification of Crohn's Disease and Ulcerative Colitis Patients Using Transcriptional Profiles in Peripheral Blood Mononuclear Cells

The Journal of Molecular Diagnostics - Tập 8 - Trang 51-61 - 2006
Michael E. Burczynski1, Ron L. Peterson2, Natalie C. Twine2, Krystyna A. Zuberek2, Brendan J. Brodeur2, Lori Casciotti2, Vasu Maganti3, Padma S. Reddy4, Andrew Strahs5, Fred Immermann6, Walter Spinelli7, Ulrich Schwertschlag8, Anna M. Slager1, Monette M. Cotreau8, Andrew J. Dorner2
1Molecular Profiling and Biomarker Discovery/Biomarker Laboratory, Wyeth Research, Collegeville, Pennsylvania
2Molecular Profiling and Biomarker Discovery, Wyeth Research, Cambridge, Massachusetts
3Inflammation Research, Wyeth Research, Cambridge, Massachusetts
4Bioinformatics Client Services, Wyeth Research, Cambridge, Massachusetts
5Clinical Statistics, Wyeth Research, Cambridge, Massachusetts
6Biometrics Research, Wyeth Research, Pearl River, New York
7Clinical Research and Development, Wyeth Research, Collegeville, Pennsylvania
8Translational Research, Wyeth Research, Cambridge, Massachusetts

Tài liệu tham khảo

Podolsky, 2002, Inflammatory bowel disease, N Engl J Med, 347, 417, 10.1056/NEJMra020831

Bouma, 2003, The immunological and genetic basis of inflammatory bowel disease, Nat Rev Immunol, 3, 521, 10.1038/nri1132

Warner, 2002, Application of genome-wide gene expression profiling by high-density DNA arrays to the treatment and study of inflammatory bowel disease, Inflamm Bowel Dis, 8, 140, 10.1097/00054725-200203000-00012

Lawrance, 2001, Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes, Hum Mol Genet, 10, 445, 10.1093/hmg/10.5.445

Rockett, 2004, Surrogate tissue analysis: monitoring toxicant exposure and health status of inaccessible tissues through the analysis of accessible tissues and cells, Toxicol Appl Pharmacol, 194, 189, 10.1016/j.taap.2003.09.005

Maas, 2002, Cutting edge: molecular portrait of human autoimmune disease, J Immunol, 169, 5, 10.4049/jimmunol.169.1.5

Twine, 2003, Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma, Cancer Res, 63, 6069

Mannick, 2004, Gene expression in mononuclear cells from patients with inflammatory bowel disease, Clin Immunol, 112, 247, 10.1016/j.clim.2004.03.014

Hill, 2001, Evaluation of normalization procedures for oligonucleotide array data based on spiked cRNA controls, Genome Biol, 2, 10.1186/gb-2001-2-12-research0055

Golub, 1999, Molecular classification of cancer: class discovery and class prediction by gene expression monitoring, Science, 286, 531, 10.1126/science.286.5439.531

Schmielau, 2001, Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients, Cancer Res, 61, 4756

De Bruin, 1988, Plasminogen activators in the intestine of patients with inflammatory bowel disease, Thromb Haemost, 60, 262, 10.1055/s-0038-1647042

Kruithof, 1995, Biological and clinical aspects of plasminogen activator inhibitor type 2, Blood, 86, 4007, 10.1182/blood.V86.11.4007.bloodjournal86114007

de Jong, 1989, Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces, Gut, 30, 188, 10.1136/gut.30.2.188

Schmidt, 1996, Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease, Hepatogastroenterology, 43, 1508

Trebble, 2004, Peripheral blood mononuclear cell fatty acid composition and inflammatory mediator production in adult Crohn's disease, Clin Nutr, 23, 647, 10.1016/j.clnu.2003.10.017

Barrera, 1996, Regulation by prostaglandin E2 of interleukin release by T lymphocytes in mucosa, J Cell Physiol, 166, 130, 10.1002/(SICI)1097-4652(199601)166:1<130::AID-JCP15>3.0.CO;2-J

Danese, 2004, Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications, Am J Gastroenterol, 99, 938, 10.1111/j.1572-0241.2004.04129.x

Gnatenko, 2003, Transcript profiling of human platelets using microarray and serial analysis of gene expression, Blood, 101, 2285, 10.1182/blood-2002-09-2797

Farrell, 2002, Ulcerative colitis, Lancet, 359, 331, 10.1016/S0140-6736(02)07499-8

Dunn-Walters, 1999, Biased JH usage in plasma cell immunoglobulin gene sequences from colonic mucosa in ulcerative colitis but not in Crohn's disease, Gut, 44, 382, 10.1136/gut.44.3.382

Thoree, 2002, Related IgA1 and IgG producing cells in blood and diseased mucosa in ulcerative colitis, Gut, 51, 44, 10.1136/gut.51.1.44

Kett, 1987, Local IgA subclass alterations in ulcerative colitis and Crohn's disease of the colon, Gut, 28, 1013, 10.1136/gut.28.8.1013

Furrie, 2004, Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response, Gut, 53, 91, 10.1136/gut.53.1.91

Gouni-Berthold, 1999, Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease, Hepatogastroenterology, 46, 1720

Winther, 1998, Inflammatory bowel disease (ulcerative colitis and Crohn's disease): diagnostic criteria and differential diagnosis, Drugs Today (Barc), 34, 935, 10.1358/dot.1998.34.11.487477

Bentley, 2002, How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop, J Clin Pathol, 55, 955, 10.1136/jcp.55.12.955

Guindi, 2004, Indeterminate colitis, J Clin Pathol, 57, 1233, 10.1136/jcp.2003.015214

Thông tin
Thông tin xuất bản

The Journal of Molecular Diagnostics

Tập 8

51-61

Thông tin tác giả